Eco Science Solutions Inc. (fka ESSI)

[investright51]

It would be absolutely wonderful to have someone give us an update of some kind on how the trials are going. In the meantime, taken from their information and emails, we are to understand that they are in clinical trials now with results that should arrive between April - June. I wonder given the fact those dates are a good 3 month spread, what would stop the CEO from giving some kind of PR on how close they are to completing these trials.
--
Homatropine has almost 40 years of visibility and is already a generic drug; therefore the trial will not be looking at toxicity which is almost always a main reason for a drugs delay in obtaining a regulatory approval. The Company anticipates that the Study will be completed, barring any unforeseen delays, some time during the 2nd calendar quarter of 2013.

The Clinical Trial will be a Phase 2-3, Prospective, Randomized, Double Blind, Placebo-Controlled, Dose Escalation, Parallel-Group-Study to Test the Efficacy and Safety of Homatropine Methylbromide Oral Suspension on Selected Climacteric Symptoms and Quality of Life in Menopausal Women Not Receiving HRT.